Novel crystalline forms of the anti-cancer compound zd1839

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 239/94 (2006.01) A61K 31/5377 (2006.01)

Patent

CA 2702297

The invention concerns certain crystalline solvates and hydrates of the compound of the Formula (I) (see formula I) which is known inter alia by way of the code number ZD1839. In particular, the invention concerns a first solvate that occurs in the presence of methanol which is designated as Form 2 ZD1839 MeOH solvate, a second solvate that occurs in the presence of dimethyl sulphoxide which is designated as Form 3 ZD1839 DMSO solvate and a trihydrate that occurs in the presence of water which is designated Form 5 ZD1839 trihydrate. The invention further concerns processes for the preparation of these solvates and the trihydrate and for their conversion back to the compound ZD1839, pharmaceutical compositions containing them and their use in the manufacture of medicaments for use in the production of an anti-proliferative effect in a warm-blooded animal such as man.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel crystalline forms of the anti-cancer compound zd1839 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel crystalline forms of the anti-cancer compound zd1839, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel crystalline forms of the anti-cancer compound zd1839 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1781834

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.